Diseases that we treat

Osteoprosis

Advantages of our treatment system:

Osteoporosis is a debilitating disease that affects millions of people around the world.It is a condition of bone fragility caused by decreased bone density making the patient highly susceptible to fractures.The consequences of a fracture in such a condition can be devastating, leading to substantial morbidity and mortality of the patient.
Current osteoporosis treatments are predominantly bone-resorbing drugs that are associated with several side effects.
Adult mesenchymal stem cells derived from bone marrow or subcutaneous fat are potential candidates for stem cell therapy, however in a study (3) when compared to bone marrow derived stem cells,adipose derived stem cells have shown superior biological properties.
Adipose derived stem cells from the elderly may become a promising therapeutic agent in geriatrics to treat skeletal diseases.
Results may vary from one patient to the other due to variables such as BMI, source, gender amd age that may affect the proliferation and differentiation of the stem cells

No risk of rejection or immune reaction involved as only the patient’s own stem cells are used.
No general anesthesia.
No risk of contamination by transmissible diseases.
No oncological complications as adult stem cells in comparison to embryonic cells are rather mature.
Procedure is very quick and simple. Small quantity of cells are extracted from bone marrow and/or fat tissue. Although combination of the two can often show  best results.
The period of time between getting the aspirate and injection of the activated stem cells is only a few hours.

References:

3. Pountos, Ippokratis MB, BSc, MSc*; Georgouli, Theodora MB, BSc, MSc*; Henshaw, Karen BSc, MPhil†; Bird, Howard MD, FRCP†; Jones, Elena PhD†; Giannoudis, Peter V MD, FRCS*The Effect of Bone Morphogenetic Protein-2, Bone Morphogenetic Protein-7, Parathyroid Hormone, and Platelet-Derived Growth Factor on the Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Osteoporotic Bone.
Journal of Orthopaedic Trauma: September 2010 – Volume 24 – Issue 9 – pp 552-556